Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Clinical Needs of Patients with Problem Drug Use.

Krupski A, West II, Graves MC, Atkins DC, Maynard C, Bumgardner K, Donovan D, Ries R, Roy-Byrne P.

J Am Board Fam Med. 2015 Sep-Oct;28(5):605-16. doi: 10.3122/jabfm.2015.05.150004.

2.

Buprenorphine implant for opioid addiction.

Ling W.

Pain Manag. 2012 Jul;2(4):345-50. doi: 10.2217/pmt.12.26.

3.

Update on the clinical use of buprenorphine: in opioid-related disorders.

Ducharme S, Fraser R, Gill K.

Can Fam Physician. 2012 Jan;58(1):37-41. Review.

4.

Opioid dependence treatment: options in pharmacotherapy.

Stotts AL, Dodrill CL, Kosten TR.

Expert Opin Pharmacother. 2009 Aug;10(11):1727-40. doi: 10.1517/14656560903037168. Review.

5.

Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization.

Virk MS, Arttamangkul S, Birdsong WT, Williams JT.

J Neurosci. 2009 Jun 3;29(22):7341-8. doi: 10.1523/JNEUROSCI.3723-08.2009.

6.

The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.

Farid WO, Dunlop SA, Tait RJ, Hulse GK.

Curr Neuropharmacol. 2008 Jun;6(2):125-50. doi: 10.2174/157015908784533842.

7.

Misuse of and dependence on opioids: study of chronic pain patients.

Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D.

Can Fam Physician. 2006 Sep;52(9):1081-7. Review.

8.

The effectiveness of community maintenance with methadone or buprenorphine for treating opiate dependence.

Simoens S, Matheson C, Bond C, Inkster K, Ludbrook A.

Br J Gen Pract. 2005 Feb;55(511):139-46. Review.

9.

Managing opioid dependence. Comparing buprenorphine with methadone.

Cavacuiti C, Selby P.

Can Fam Physician. 2003 Jul;49:876-7. No abstract available.

Items per page

Supplemental Content

Support Center